PMC:7283670 / 64424-64860 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T372","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"T373","span":{"begin":236,"end":245},"obj":"Disease"},{"id":"T374","span":{"begin":275,"end":283},"obj":"Disease"}],"attributes":[{"id":"A372","pred":"mondo_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A373","pred":"mondo_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A374","pred":"mondo_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T589","span":{"begin":307,"end":309},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T172","span":{"begin":159,"end":170},"obj":"Chemical"},{"id":"T173","span":{"begin":178,"end":186},"obj":"Chemical"},{"id":"T174","span":{"begin":253,"end":264},"obj":"Chemical"},{"id":"T175","span":{"begin":284,"end":295},"obj":"Chemical"},{"id":"T176","span":{"begin":366,"end":371},"obj":"Chemical"},{"id":"T177","span":{"begin":423,"end":434},"obj":"Chemical"}],"attributes":[{"id":"A172","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A173","pred":"chebi_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A174","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A176","pred":"chebi_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A177","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}

{"project":"LitCovid-sentences","denotations":[{"id":"T646","span":{"begin":132,"end":408},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T224","span":{"begin":236,"end":245},"obj":"Phenotype"}],"attributes":[{"id":"A224","pred":"hp_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1900","span":{"begin":209,"end":224},"obj":"Species"},{"id":"2133","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"2134","span":{"begin":236,"end":245},"obj":"Disease"},{"id":"2135","span":{"begin":275,"end":283},"obj":"Disease"}],"attributes":[{"id":"A1900","pred":"tao:has_database_id","subj":"1900","obj":"Tax:2697049"},{"id":"A2133","pred":"tao:has_database_id","subj":"2133","obj":"MESH:C000657245"},{"id":"A2134","pred":"tao:has_database_id","subj":"2134","obj":"MESH:D011014"},{"id":"A2135","pred":"tao:has_database_id","subj":"2135","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ents whose oxygenation index increased by 100 mmHg on the 7th day after admission NCT04305106/Not yet recruiting, Mar12‐May31 2020\nThe efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days\nExperimental: thalidomide g"}